Table 1 Summary of DEGs between treatment groups in the study.

From: Transcriptomic analysis of glutamate-induced HT22 neurotoxicity as a model for screening anti-Alzheimer’s drugs

Comparisons

Up-regulated genes

Down-regulated genes

Total DEGs

Control vs Glutamate

117 (41.1%)

168 (58.9%)

285

Glutamate vs AE_Et50

195 (60.6%)

127 (39.4%)

322

Glutamate vs SA_Et50

264 (57.5%)

195 (42.5%)

459